GlaxoSmithKline said it had appointed Tony Wood as chief scientific officer designate after Hall Barron said he was resigning the post to run a new privately owned start-up biotech company.
.
Wood, who joined GSK from Pfizer in 2017, will take over on August 1. Barron is joining Altos Labs, a new biotech company based in San Francisco, California as chief executive and co-chair.
Altos is focused on the biology of cellular rejuvenation programming with the goal of reversing disease, GSK said.
(Sharecast News) - Ladbrokes owner Entain rallied on Wednesday as it announced the appointment of Eminence Capital founder Ricky Sandler as a non-executive director with immediate effect. Sandler is the founder, chief executive and chief investment officer of Eminence...
(Sharecast News) - Budget airline Ryanair reported a 9% jump in December passenger numbers on Wednesday. Traffic rose to 12.54 million from 11.52m in the same month a year earlier, while the load factor - which gauges how full the planes are - ticked down to 91% from...
(Sharecast News) - Hungary-based budget airline Wizz Air reported a strong rise in December passenger numbers as demand continued to rebound from the Covid pandemic. The company on Wednesday said it carried 4,964,857 passengers, an 18.8% increase year on year. For the...
Subscribe to our mailing list to receive regular updates!
